Welcome to LookChem.com Sign In|Join Free

CAS

  • or
QUINAZOLIN-4-YLAMINE, with the molecular formula C8H7N3, is a heterocyclic amine characterized by its quinazoline ring structure. It serves as a fundamental building block in the synthesis of pharmaceuticals and other organic compounds. Recognized for its role in the development of bioactive molecules, QUINAZOLIN-4-YLAMINE has garnered attention for its potential applications in various therapeutic areas, including antiviral and anticancer treatments, as well as in managing conditions like diabetes and hypertension.

15018-66-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 15018-66-3 Structure
  • Basic information

    1. Product Name: QUINAZOLIN-4-YLAMINE
    2. Synonyms: QUINAZOLIN-4-YLAMINE;4-QUINAZOLINAMINE;4-QUINAZOLINEAMINE;4-QUINAZOLINYLAMINE;4-Quinazolinamine (9CI);4-AMINOQUINAZOLINE ;quinazolin-4-amine;Quinazoline-4-amine
    3. CAS NO:15018-66-3
    4. Molecular Formula: C8H7N3
    5. Molecular Weight: 145.16
    6. EINECS: N/A
    7. Product Categories: PYRIMIDINE
    8. Mol File: 15018-66-3.mol
  • Chemical Properties

    1. Melting Point: 274-275℃
    2. Boiling Point: 328.3 °C at 760 mmHg
    3. Flash Point: 178.6 °C
    4. Appearance: /Solid
    5. Density: 1.292 g/cm3
    6. Vapor Pressure: 0.000191mmHg at 25°C
    7. Refractive Index: 1.723
    8. Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
    9. Solubility: N/A
    10. PKA: 5.86±0.30(Predicted)
    11. CAS DataBase Reference: QUINAZOLIN-4-YLAMINE(CAS DataBase Reference)
    12. NIST Chemistry Reference: QUINAZOLIN-4-YLAMINE(15018-66-3)
    13. EPA Substance Registry System: QUINAZOLIN-4-YLAMINE(15018-66-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: 41
    3. Safety Statements: 26-39
    4. RIDADR: 2811
    5. WGK Germany:
    6. RTECS: VA1236000
    7. HazardClass: IRRITANT
    8. PackingGroup:
    9. Hazardous Substances Data: 15018-66-3(Hazardous Substances Data)

15018-66-3 Usage

Uses

Used in Pharmaceutical Industry:
QUINAZOLIN-4-YLAMINE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of bioactive molecules with potential therapeutic effects.
Used in Antiviral Applications:
In antiviral research, QUINAZOLIN-4-YLAMINE is utilized as a component in the creation of antiviral agents, aiming to inhibit viral replication and reduce the impact of viral infections.
Used in Anticancer Applications:
As a part of cancer research, QUINAZOLIN-4-YLAMINE is employed in the design of anticancer agents, targeting the inhibition of cancer cell growth and the disruption of tumor progression.
Used in Treatment of Chronic Conditions:
In the medical field, QUINAZOLIN-4-YLAMINE is used as a component in the development of treatments for chronic conditions such as diabetes and hypertension, due to its potential role in managing these diseases at a molecular level.
Used in Organic Chemistry:
In the realm of organic chemistry, QUINAZOLIN-4-YLAMINE is utilized as a versatile building block for the synthesis of a wide range of organic compounds, highlighting its importance in chemical research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 15018-66-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,0,1 and 8 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 15018-66:
(7*1)+(6*5)+(5*0)+(4*1)+(3*8)+(2*6)+(1*6)=83
83 % 10 = 3
So 15018-66-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H7N3/c9-8-6-3-1-2-4-7(6)10-5-11-8/h1-5H,(H2,9,10,11)

15018-66-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H66948)  4-Aminoquinazoline, 97%   

  • 15018-66-3

  • 1g

  • 1582.0CNY

  • Detail
  • Alfa Aesar

  • (H66948)  4-Aminoquinazoline, 97%   

  • 15018-66-3

  • 5g

  • 6356.0CNY

  • Detail
  • Aldrich

  • (CBR00181)  4-Quinazolinamine  AldrichCPR

  • 15018-66-3

  • CBR00181-1G

  • 3,221.01CNY

  • Detail

15018-66-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name quinazolin-4-amine

1.2 Other means of identification

Product number -
Other names Chinazolin-4-ylamin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15018-66-3 SDS

15018-66-3Relevant articles and documents

Synthesis of new tetracyclic azaheteroaromatic cores via auto-tandem Pd-catalyzed and one-pot Pd- and Cu-catalyzed double C-N bond formation

Rauws, Tom R.M.,Biancalani, Claudio,De Schutter, Joris W.,Maes, Bert U.W.

, p. 6958 - 6964 (2010)

Inter- and intramolecular transition metal-catalyzed amination of 2-chloro-3-iodopyridine and 2,3-dibromopyridine, respectively, with benzodiazinamines yielded six hitherto unknown tetracyclic azaheteroaromatic cores. C-N bond formation was achieved via auto-tandem (Pd-catalyst) as well as one-pot (sequential use of a Pd- and Cu-catalyst) catalysis.

Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin

Kakoulidou, Chrisoula,Gritzapis, Panagiotis S.,Hatzidimitriou, Antonios G.,Fylaktakidou, Konstantina C.,Psomas, George

, (2020)

The interaction of the novel quinazoline (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline (L) with Zn2+ was performed in the absence or presence of the non-steroidal anti-inflammatory drug sodium diclofenac (Nadicl) and resulted in the fo

One-pot three-component synthesis of 2-substituted 4-aminoquinazolines

Rad-Moghadam, Kurosh,Samavi, Laleh

, p. 913 - 916 (2006)

A facile and rapid synthesis of the title compounds via one-pot reaction of 2-aminobenzonitrile, orthoesters and ammonium acetate under solvent-free and microwave condition is described.

Novel compound or pharmaceutically acceptable salt thereof and pharmaceutical composition for prevention or treatment of disease caused by influenza virus infection containing the same as an active ingredient

-

Paragraph 0680; 0682, (2016/10/07)

The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active component for preventing or treating diseases related with influenza virus infection. The novel compound represented by chemical formula 1 has remarkable antivirus activity against influenza virus without cytotoxicity to human cells and thus has little side effects to human bodies. Therefore, the pharmaceutical composition having the same as an active component can be usefully used for preventing or treating diseases which occur through influenza virus infection such as flu, cold, sore throat, bronchitis, pneumonia, avian influenza, swine flu, goat flu, etc.COPYRIGHT KIPO 2016

Microwave-assisted thermal decomposition of formamide: A tool for coupling a pyrimidine ring with an aromatic partner

Loidreau, Yvonnick,Besson, Thierry

, p. 4852 - 4857 (2011/08/06)

Rapid and efficient generation of CO and NH3 in the reaction mixture via microwave-assisted thermal decomposition of formamide may represent a significant improvement over existing methods for coupling a pyrimidine ring with an aromatic partner. This work aims at alerting readers on the probability to observe interesting phenomena and reactions when this very powerful heating mode is associated with thermally unstable reagents.

Synthesis of a new isomer of creatinine and its use in the preparation of the food mutagen 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine (PHIP)

Bergman, Jan

scheme or table, p. 5631 - 5632 (2011/02/22)

Base-induced cyclization of N′-cyanomethyl-N′-methylurea gives 1-methyl-4-amino-imidazol-2-one, this in turn is condensed with 3-hydroxy-2-phenylacrolein to yield an imidazo[4,5-b]pyridine which is converted into 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine (PHIP).

Inhibitors of apoptosis in lymphocytes: Synthesis and biological evaluation of compounds related to pifithrin-α

Barchéchath, Sylvie D.,Tawatao, Rommel I.,Corr, Maripat,Carson, Dennis A.,Cottam, Howard B.

, p. 6409 - 6422 (2007/10/03)

The chemoprotection of cells from apoptosis induced by toxins or ionizing radiation could be important for biodefense and in the treatment of acute injuries. We describe a series of small heterocycles, including fused benzothiazoles, benzimidazoles, and related compounds, that abrogate thymocyte apoptosis induced by dexamethasone and γ-irradiation. To optimize the protective activity of the previously reported pifithrin-α (PFT-α, 1), various derivatives and analogues of this and the corresponding ring-closed imidazobenzothiazole (IBT, 39) were synthesized. The aromatic analogues of 39 were more protective than 39, while the aromatic analogues of 1 were not active. Compound 19 containing a pyrrolidinyl substituent on the phenyl ring provided potent antiapoptotic activity (EC50 of 1.31 μM compared to 4.16 μM for 1). Modification of aromatic 39 with a pyrrolidinyl para substituent (compound 60) enhanced the activity, lowering the EC50 to 0.35 μM. Also, 60 provided significant protection against γ-irradiation-induced apoptosis, as expected. Compounds 19 and 60 may be promising for potential clinical development.

A new application of diphenylphosphorylazide (DPPA) reagent: Convenient transformations of quinolin-4-one, pyridin-4-one and quinazolin-4-one derivatives into the 4-azido and 4-amino counterparts

Aizikovich, Alexander,Kuznetsov, Vladimir,Gorohovsky, Sofia,Levy, Amalia,Meir, Simha,Byk, Gerardo,Gellerman, Garry

, p. 4241 - 4243 (2007/10/03)

Herein, we describe a transformation of the oxo-function of a series of quinolin/pyridin/quinazolin-4-ones into 4-azido and thence into 4-amino derivatives in moderate yields by a very short and convenient new procedure using DPPA (diphenylphosphoryl azide) as reagent. A mechanism for this interesting new application of DPPA is suggested based on the identification of some of the intermediates.

Isoquinoline and quinazoline urea analogues as antagonists for the human-adenosine A3 receptor

Van Muijlwijk-Koezen, Jacqueline E.,Timmerman, Henk,Van Der Goot, Henk,Menge, Wiro M. P. B.,Von Drabbe Künzel, Jacobien Frijtag,De Groote, Miriam,Ijzerman, Adriaan P.

, p. 2227 - 2238 (2007/10/03)

Isoquinoline and quinazoline urea derivatives were found to bind to human adenosine AS receptors. Series of N-phenyl-N'-quinazolin-4-ylurea derivatives and N-phenyl-N'-isoquinolin-1-ylurea derivatives were synthesized and tested in radioligand binding ass

Heterocyclic Compounds with a Bridgehead Nitrogen Atom. Synthesis in the Imidazoquinazoline Series

Gueiffier, A.,Viols, H.,Chapat, J. P.,Chavignon, O.,Teulade, J. C.,Dauphin, G.

, p. 421 - 425 (2007/10/02)

The structures of imidazoquinazolines were reexaminated and established by spectroscopic studies with the aid of high-field 1H and 13C nmr and mass spectra.In acidic media, 3 reacts to give the products of electrophilic substitution reaction and ring opening compound 5, leading to the imidazobenzotriazine ring.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15018-66-3